4//SEC Filing
Arbet-Engels Christophe 4
Accession 0001628280-23-031389
CIK 0001501697other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:15 PM ET
Size
5.6 KB
Accession
0001628280-23-031389
Insider Transaction Report
Form 4
Arbet-Engels Christophe
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-08-31$1.28/sh+1,250,000$1,600,000→ 1,250,000 totalExercise: $1.28Exp: 2033-08-30→ Common Stock (1,250,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on August 31, 2024, with the remainder vesting in equal installments of 2.0833% of the shares subject to the option each successive month thereafter for a period of 36 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001802615
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:15 PM ET
- Size
- 5.6 KB